(UPXI) Upexi - Ratings and Ratios
Film, Media, Entertainment, Content, Production
UPXI EPS (Earnings per Share)
UPXI Revenue
Description: UPXI Upexi
Upexi Inc. (NASDAQ:UPXI) is a US-based company operating in the Movies & Entertainment sub-industry. To assess its viability, well need to examine key performance indicators (KPIs) and economic drivers. A crucial metric is revenue growth, which is essential for understanding the companys ability to expand its operations. Additionally, the gross margin ratio will provide insight into Upexis pricing power and cost management.
The companys market capitalization stands at $301.78M USD, indicating a relatively small-cap stock. The forward Price-to-Earnings (P/E) ratio is 188.68, suggesting that investors have high expectations for future earnings growth. However, the Return on Equity (RoE) is -133.05, implying significant losses. To turn this around, Upexi must focus on improving its operational efficiency and reducing costs.
To drive growth, Upexi should concentrate on key economic drivers such as demand for its services or products within the Movies & Entertainment industry. The companys ability to adapt to changing consumer preferences and technological advancements will be crucial. Key metrics to monitor include revenue diversification, customer acquisition costs, and retention rates. By focusing on these areas, Upexi can work towards achieving sustainable growth and improving its financial performance.
From a trading perspective, Upexis stock has a beta of -0.492, indicating an inverse relationship with the broader market. This could be attractive to investors seeking to hedge their portfolios. However, the Average True Range (ATR) is 10.41%, suggesting significant price volatility. To mitigate this risk, investors should closely monitor the stocks price movements and adjust their strategies accordingly.
UPXI Stock Overview
| Market Cap in USD | 409m |
| Sub-Industry | Movies & Entertainment |
| IPO / Inception | 2021-06-24 |
UPXI Stock Ratings
| Growth Rating | -32.9% |
| Fundamental | 15.2% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 50.8% |
| Analyst Rating | - |
UPXI Dividends
Currently no dividends paidUPXI Growth Ratios
| Growth Correlation 3m | -22.6% |
| Growth Correlation 12m | 35.3% |
| Growth Correlation 5y | -93% |
| CAGR 5y | -48.19% |
| CAGR/Max DD 5y | -0.49 |
| Sharpe Ratio 12m | -0.68 |
| Alpha | 62.31 |
| Beta | 1.403 |
| Volatility | 118.89% |
| Current Volume | 4475.9k |
| Average Volume 20d | 6594.5k |
| Stop Loss | 6.7 (-7.3%) |
| Signal | -2.41 |
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (-10.9m TTM) > 0 and > 6% of Revenue (6% = 1.56m TTM) |
| FCFTA -0.07 (>2.0%) and ΔFCFTA -5.56pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -26.29% (prev -14.97%; Δ -11.32pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.32 (>3.0%) and CFO -4.83m > Net Income -10.9m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 0.37 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.34m) change vs 12m ago 27.84% (target <= -2.0% for YES) |
| Gross Margin 39.84% (prev 37.74%; Δ 2.10pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 72.56% (prev 86.90%; Δ -14.34pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -9.62 (EBITDA TTM -5.72m / Interest Expense TTM 763.6k) >= 6 (WARN >= 3) |
Altman Z'' -20.21
| (A) -0.45 = (Total Current Assets 3.97m - Total Current Liabilities 10.8m) / Total Assets 15.1m |
| (B) -3.56 = Retained Earnings (Balance) -53.6m / Total Assets 15.1m |
| warn (B) unusual magnitude: -3.56 — check mapping/units |
| (C) -0.21 = EBIT TTM -7.35m / Avg Total Assets 35.8m |
| (D) -4.06 = Book Value of Equity -53.6m / Total Liabilities 13.2m |
| Total Rating: -20.21 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 15.15
| 1. Piotroski 2.0pt = -3.0 |
| 2. FCF Yield -0.25% = -0.12 |
| 3. FCF Margin -3.98% = -1.49 |
| 4. Debt/Equity 4.02 = -2.04 |
| 5. Debt/Ebitda -1.30 = -2.50 |
| 6. ROIC - WACC -68.37% = -12.50 |
| 7. RoE -133.0% = -2.50 |
| 8. Rev. Trend -76.48% = -3.82 |
| 9. Rev. CAGR -43.51% = -2.50 |
| 10. EPS Trend -74.56% = -1.86 |
| 11. EPS CAGR -189.8% = -2.50 |
What is the price of UPXI shares?
Over the past week, the price has changed by -8.83%, over one month by +33.15%, over three months by -26.67% and over the past year by +76.34%.
Is Upexi a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UPXI is around 5.41 USD . This means that UPXI is currently overvalued and has a potential downside of -25.17%.
Is UPXI a buy, sell or hold?
What are the forecasts/targets for the UPXI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.5 | 114.4% |
| Analysts Target Price | 25 | 245.8% |
| ValueRay Target Price | 6.2 | -14.7% |
Last update: 2025-08-23 04:52
UPXI Fundamental Data Overview
CCE Cash And Equivalents = 230.4k USD (Cash And Short Term Investments, last quarter)
P/E Forward = 232.5581
P/S = 24.7016
P/B = 221.0765
Beta = -0.492
Revenue TTM = 26.0m USD
EBIT TTM = -7.35m USD
EBITDA TTM = -5.72m USD
Long Term Debt = 576.2k USD (from longTermDebt, last quarter)
Short Term Debt = 6.87m USD (from shortTermDebt, last quarter)
Debt = 7.44m USD (Calculated: Short Term 6.87m + Long Term 576.2k)
Net Debt = 9.06m USD (from netDebt column, last quarter)
Enterprise Value = 416.3m USD (409.1m + Debt 7.44m - CCE 230.4k)
Interest Coverage Ratio = -9.62 (Ebit TTM -7.35m / Interest Expense TTM 763.6k)
FCF Yield = -0.25% (FCF TTM -1.03m / Enterprise Value 416.3m)
FCF Margin = -3.98% (FCF TTM -1.03m / Revenue TTM 26.0m)
Net Margin = -41.89% (Net Income TTM -10.9m / Revenue TTM 26.0m)
Gross Margin = 39.84% ((Revenue TTM 26.0m - Cost of Revenue TTM 15.6m) / Revenue TTM)
Tobins Q-Ratio = -7.76 (set to none) (Enterprise Value 416.3m / Book Value Of Equity -53.6m)
Interest Expense / Debt = 3.29% (Interest Expense 245.1k / Debt 7.44m)
Taxrate = 21.0% (US default)
NOPAT = -7.35m (EBIT -7.35m, no tax applied on loss)
Current Ratio = 0.37 (Total Current Assets 3.97m / Total Current Liabilities 10.8m)
Debt / Equity = 4.02 (Debt 7.44m / last Quarter total Stockholder Equity 1.85m)
Debt / EBITDA = -1.30 (Net Debt 9.06m / EBITDA -5.72m)
Debt / FCF = -7.20 (Debt 7.44m / FCF TTM -1.03m)
Total Stockholder Equity = 8.18m (last 4 quarters mean)
RoA = -72.19% (Net Income -10.9m, Total Assets 15.1m )
RoE = -133.0% (Net Income TTM -10.9m / Total Stockholder Equity 8.18m)
RoCE = -83.93% (Ebit -7.35m / (Equity 8.18m + L.T.Debt 576.2k))
RoIC = -57.34% (NOPAT -7.35m / Invested Capital 12.8m)
WACC = 11.04% (E(409.1m)/V(416.6m) * Re(11.19%)) + (D(7.44m)/V(416.6m) * Rd(3.29%) * (1-Tc(0.21)))
Shares Correlation 5-Years: -50.0 | Cagr: -47.57%
Discount Rate = 11.19% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -1.03m)
Revenue Correlation: -76.48 | Revenue CAGR: -43.51%
Rev Growth-of-Growth: -41.72
EPS Correlation: -74.56 | EPS CAGR: -189.8%
EPS Growth-of-Growth: 0.65
Additional Sources for UPXI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle